Synergistic combination
US7056936B2 · kind B2 · utility
10Cited by
9References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2003 |
| Grant date | Jun 6, 2006 |
| Priority date | — |
| Expiry date | May 14, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the combined administration of PDE inhibitors and β2 adrenoceptor agonists for the treatment of respiratory tract disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.